We carried out transcatheter procedures to close postinfarction ventricular septal defects
(PIVSDs) in 19 patients: two had recanalization after surgical closure, and 17 had a primary …

Aim To report the periprocedural and long-term results of using the Amplatzer septal
occluder for primary closure of post myocardial infarction ventricular septal defects. Methods …

Objective: Postinfarction ventricular septal defect (PIVSD) is a rare and life-threatening
complication with high risk of both surgical and medical treatment. Another option available …

The management of postinfarction ventricular septal defects represents a challenge to both
cardiologists and surgeons due to the high morbidity and mortality rate. We report the case …

A best evidence topic in cardiac surgery was written according to a structured protocol. The
question addressed was 'Is the placement of an Amplatzer septal occluder device across a …

The initial therapy for postmyocardial infarction ventricular septal defects is surgical repair of
the defect. Unfortunately, a significant number of patients develop recurrent ventricular …

Background—The interest in transcatheter ventricular septal defect (VSD) closure is
continuously growing. Therefore, we report our experience in perimembranous (Pm) and …

There is an 80-90% mortality rate within the first 2 months of the occurrence of a post-
infarction ventricular septal defect (VSD) with medical treatment alone. The muscular VSD …

The objective of this study was to assess the immediate and mid‐term results of
transcatheter closure of postinfarct muscular ventricular septal defects (VSDs) using the new …

Rupture of the interventricular septum is an uncommon but often fatal complication of acute
myocardial infarction. Transcatheter closure is an established method of treating selected …